(Q47601081)

4 February 2018

title

Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization (English)

1 reference

4 February 2018

1 reference

1 reference

1 reference

1 reference

5

1 reference

4 February 2018

author name string

Estella M Davis

1

1 reference

4 February 2018

Carla M Christensen

2

1 reference

4 February 2018

Kelly K Nystrom

3

1 reference

4 February 2018

Pamela A Foral

4

1 reference

4 February 2018

publication date

1 July 2008

1 reference

4 February 2018

American Journal of Health-System Pharmacy

published in

1 reference

4 February 2018

volume

65

1 reference

4 February 2018

issue

14

1 reference

4 February 2018

page(s)

1347-1357

1 reference

4 February 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

A comparison of insulin pen use in the United States and the United Kingdom

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Patient perceptions of diabetes and diabetes therapy: assessing quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Preference for insulin delivery systems among current insulin users and nonusers.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070636

31 March 2020

Identifiers

DOI

10.2146/AJHP070636

1 reference

4 February 2018

1 reference

4 February 2018